Insulin aspart, recombinant Subcutaneous and Nipride RTU
Determining the interaction of Insulin aspart, recombinant Subcutaneous and Nipride RTU and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
Generic Name: nitroprusside
Brand name: Nipride RTU, Nitropress
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin aspart, recombinant Subcutaneous-Niraparib
- Insulin aspart, recombinant Subcutaneous-Niraparib Tosylate
- Insulin aspart, recombinant Subcutaneous-Niravam
- Insulin aspart, recombinant Subcutaneous-Niravam Oral
- Insulin aspart, recombinant Subcutaneous-Niron Komplete
- Insulin aspart, recombinant Subcutaneous-Nisoldipine
- Nipride RTU-Insulin degludec
- Nipride RTU-Insulin Degludec (U-100) Prefilled Pens
- Nipride RTU-Insulin Degludec (U-100) Vials
- Nipride RTU-Insulin Degludec (U-200) Prefilled Pens
- Nipride RTU-Insulin degludec and liraglutide
- Nipride RTU-Insulin degludec and liraglutide Subcutaneous